chr19-5786803-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_020175.3(DUS3L):c.1432G>A(p.Asp478Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,611,978 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020175.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUS3L | NM_020175.3 | c.1432G>A | p.Asp478Asn | missense_variant | 9/13 | ENST00000309061.12 | NP_064560.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUS3L | ENST00000309061.12 | c.1432G>A | p.Asp478Asn | missense_variant | 9/13 | 1 | NM_020175.3 | ENSP00000311977.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000365 AC: 9AN: 246318Hom.: 1 AF XY: 0.0000599 AC XY: 8AN XY: 133508
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1459810Hom.: 1 Cov.: 34 AF XY: 0.0000592 AC XY: 43AN XY: 726106
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | The c.1432G>A (p.D478N) alteration is located in exon 9 (coding exon 9) of the DUS3L gene. This alteration results from a G to A substitution at nucleotide position 1432, causing the aspartic acid (D) at amino acid position 478 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at